How to avoid over-suppression of the immune system during Besudil treatment?

Belumosudil (Belumosudil) is a ROCK2 (Rho-related coiled-coil kinase2) inhibitor, mainly used to treat chronic graft-versus-host disease (cGVHD). The drug mitigates immune attacks by modulating the function of immune cells, but if immune suppression is excessive, it may increase the risk of infection and other immune-related side effects. Therefore, during treatment, measures need to be taken to balance the immunosuppressive effects and avoid over-suppression.

1. Monitor immune function and infection risk: During the use of besudil, the patient's immune status should be regularly evaluated, including white blood cell count, lymphocyte subset analysis, and inflammatory markers (such as Creactive protein). In addition, patients should be regularly screened for infections, especially for bacterial, viral, and fungal infections, such as pulmonary infection, sepsis, or shingles. For immunocompromised patients, doctors may consider prophylactic anti-infective treatment, such as antibiotics, antivirals, or antifungals.

2. Adjust the dose appropriately: The immunomodulatory effect of besudil is dose-dependent. If the patient shows signs of severe infection or excessive immune function suppression, the dose may need to be adjusted or treatment suspended. In addition, when combined with other immunosuppressive drugs (such as steroids, JAK inhibitors), the dose should be carefully selected to avoid additive immunosuppressive effects.

3. Maintain immune balance: While suppressing immunity, Besudil can also promote the recovery of immune tolerance, so it can control GVHD while reducing long-term damage to the immune system. Doctors should adjust the treatment plan based on the patient's response to ensure disease control while maintaining a certain immune function to reduce the risk of infection and other complications.

4. Preventive management strategy: In addition to drug monitoring, patients should receive appropriate vaccines (such as influenza vaccine, pneumonia vaccine) to enhance resistance to common infections. In addition, patients are advised to maintain good hygiene habits, such as washing hands frequently and avoiding crowded areas, to reduce the risk of infection.

In summary, during besudil treatment, regular monitoring, dose adjustment, immune balance maintenance and preventive measures are required to avoid excessive suppression of the immune system while ensuring the safety and effectiveness of the treatment.